Dr Shubir Sofat, MD in Rockville, MD - Medicare Cardiovascular Disease (cardiology)

Dr Shubir Sofat, MD is a medicare enrolled "Internal Medicine - Cardiovascular Disease" physician in Rockville, Maryland. He graduated from medical school in 1992 and has 32 years of diverse experience with area of expertise as Cardiovascular Disease (cardiology). He is a member of the group practice Montgomery Cardiology, Llc and his current practice location is 10110 Molecular Dr Ste 200, Rockville, Maryland. You can reach out to his office (for appointments etc.) via phone at (301) 610-4000.

Dr Shubir Sofat is licensed to practice in Maryland (license number D0055068) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1003816836.

Contact Information

	Dr Shubir Sofat, MD
	10110 Molecular Dr Ste 200, Rockville, MD 20850-7542
	(301) 610-4000
	(301) 610-4007

Physician's Profile

Full Name	Dr Shubir Sofat
Gender	Male
Speciality	Cardiovascular Disease (cardiology)
Experience	32 Years
Location	10110 Molecular Dr Ste 200, Rockville, Maryland
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Shubir Sofat graduated from medical school in 1992

NPI Data:

NPI Number: 1003816836
Provider Enumeration Date: 07/22/2005
Last Update Date: 10/06/2020

Medicare PECOS Information:

PECOS PAC ID: 0547330169
Enrollment ID: I20080609000103

Medical Identifiers

Medical identifiers for Dr Shubir Sofat such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1003816836	NPI	-	NPPES
145504400	Medicaid	MD

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RC0000X	Internal Medicine - Cardiovascular Disease	D0055068 (Maryland)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Montgomery Cardiology, Llc	0648346916	2

News Archive

Warner Chilcott to acquire U.S. rights to Enablex from Novartis for $400 million

Warner Chilcott plc today announced that it has agreed to terminate its existing co-promotion agreement with Novartis and signed a definitive agreement to purchase the U.S. rights to Enablex® from Novartis for $400 million in cash. Enablex (darifenacin) is a product indicated to treat adults with symptoms of overactive bladder, which had U.S. sales of approximately $190 million for the year ended December 31, 2009.

Study examines accuracy, effectiveness of pre-sport participation ECG screenings

Incidents of young athletes collapsing during sports practice due to an undiagnosed heart condition are alarming, and have led some health care professionals to call for mandatory electrocardiogram (ECG) screenings before sport participation.

Researchers develop model that completes bridge between cellular and human studies of schizophrenia

Schizophrenia is one of the most devastating neurological conditions, with only 30 percent of sufferers ever experiencing full recovery. While current medications can control most psychotic symptoms, their side effects can leave individuals so severely impaired that the disease ranks among the top ten causes of disability in developed countries.

Efficacy data from Phase III STAR trial of Zenvia presented at AAN Annual Meeting

AVANIR Pharmaceuticals, Inc. today announced long-term efficacy data from the 12-week double-blind phase and the 12-week open-label extension phase of the confirmatory Phase III STAR trial evaluating Zenvia™ (dextromethorphan/quinidine) in the treatment of pseudobulbar affect in patients with underlying multiple sclerosis or amyotrophic lateral sclerosis.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Shubir Sofat allows following entities to bill medicare on his behalf.

Entity Name	Adventist Physician Services Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1376623207 PECOS PAC ID: 4284631540 Enrollment ID: O20061030000122

News Archive

Warner Chilcott to acquire U.S. rights to Enablex from Novartis for $400 million

Study examines accuracy, effectiveness of pre-sport participation ECG screenings

Researchers develop model that completes bridge between cellular and human studies of schizophrenia

Efficacy data from Phase III STAR trial of Zenvia presented at AAN Annual Meeting

Entity Name	Montgomery Cardiology, Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1790785616 PECOS PAC ID: 0648346916 Enrollment ID: O20080910000456

Warner Chilcott to acquire U.S. rights to Enablex from Novartis for $400 million

Study examines accuracy, effectiveness of pre-sport participation ECG screenings

Researchers develop model that completes bridge between cellular and human studies of schizophrenia

Efficacy data from Phase III STAR trial of Zenvia presented at AAN Annual Meeting

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Shubir Sofat is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Shubir Sofat, MD 12013 Great Elm Dr, Potomac, MD 20854-1227 Ph: (301) 610-4000	Dr Shubir Sofat, MD 10110 Molecular Dr Ste 200, Rockville, MD 20850-7542 Ph: (301) 610-4000

News Archive

Warner Chilcott to acquire U.S. rights to Enablex from Novartis for $400 million

Study examines accuracy, effectiveness of pre-sport participation ECG screenings

Researchers develop model that completes bridge between cellular and human studies of schizophrenia

Efficacy data from Phase III STAR trial of Zenvia presented at AAN Annual Meeting

Internal Medicine Doctors in Rockville, MD

Dr. Sheila Gay Levin, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 14955 Shady Grove Rd, Suite 150, Rockville, MD 20850 Phone: 301-340-3252 Fax: 301-340-1423
Dr. Kajal Dasgupta, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2101 E Jefferson St, Kaiser Permanente Medicare Enrollment, Rockville, MD 20852 Phone: 301-816-2424
Joseph M Haggerty, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 9707 Medical Center Dr, Suite 300, Rockville, MD 20850 Phone: 301-424-6231 Fax: 301-294-4648
Isabelle A Hertig, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 11125 Rockville Pike, Suite 208, Rockville, MD 20852 Phone: 301-881-5858 Fax: 301-260-2838
Dr. Wellington Sun, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1401 Rockville Pike, Suite 300n, Rockville, MD 20852 Phone: 301-827-3070 Fax: 301-827-3532
Dr. Wei Fan, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2401 Research Blvd Ste 370, Rockville, MD 20850 Phone: 240-690-4114 Fax: 240-654-3915

Dr Shubir Sofat, MD - Medicare Cardiovascular Disease (cardiology) in Rockville, MD

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Warner Chilcott to acquire U.S. rights to Enablex from Novartis for $400 million

Study examines accuracy, effectiveness of pre-sport participation ECG screenings

Researchers develop model that completes bridge between cellular and human studies of schizophrenia

Efficacy data from Phase III STAR trial of Zenvia presented at AAN Annual Meeting

Medicare Reassignments

Warner Chilcott to acquire U.S. rights to Enablex from Novartis for $400 million

Study examines accuracy, effectiveness of pre-sport participation ECG screenings

Researchers develop model that completes bridge between cellular and human studies of schizophrenia

Efficacy data from Phase III STAR trial of Zenvia presented at AAN Annual Meeting

Warner Chilcott to acquire U.S. rights to Enablex from Novartis for $400 million

Study examines accuracy, effectiveness of pre-sport participation ECG screenings

Researchers develop model that completes bridge between cellular and human studies of schizophrenia

Efficacy data from Phase III STAR trial of Zenvia presented at AAN Annual Meeting

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Warner Chilcott to acquire U.S. rights to Enablex from Novartis for $400 million

Study examines accuracy, effectiveness of pre-sport participation ECG screenings

Researchers develop model that completes bridge between cellular and human studies of schizophrenia

Efficacy data from Phase III STAR trial of Zenvia presented at AAN Annual Meeting

Internal Medicine Doctors in Rockville, MD